IDNs

Outcomes-based agreements (OBA) have been endorsed by many payers as the next chapter in the value transformation. But if we move beyond the initial excitement and PR, where does pharma stand on risk-sharing and innovative contracting?

Analytica Laser’s consulting teams have taken an in-depth look behind the scenes, analyzing successful deal modalities and interviewing payers and industry pioneers for our 60-page executive report on the “new frontier in US contracting”.

Download your copy for:

  • Detailed OBA landscape assessment and break-down of deal parameters and key success factors
  • First-hand experiences distilled into a “6-Stage process” how to structure your OBA approach from conception to data analysis
  • A seat at the negotiating table with personal perspectives from leaders at Harvard Pilgrim, Tesaro and others
  • Insights into cutting-edge analytics tools that model and predict marketplace success to optimize your resources and risk exposure

* I understand that Analytica Laser will use the above data to send me the requested information, and may follow up with me on related webinars, whitepapers, articles, or service offerings. You can opt-out of our thought leadership with 1 click at any time, and trust that Analytica Laser will never sell or share your data, as outlined in our strict privacy policy.

2018-12-06T15:29:03+01:00